Rat Slc12a5/Kcc2 ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_134363.1)

Cat. No.: pGMAAV000414
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Rat Slc12a5/Kcc2 Adeno-associated virus expression plasmid (ITR-vector) for Slc12a5 AAV packaging, Slc12a5 AAV production.The purified Rat Slc12a5/Kcc2 AAV particle serves as an invaluable asset for in-depth in vivo Slc12a5 studies, mechanism of action (MOA) research, and the evolution of Slc12a5-associated gene therapy strategies.

Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAAV000414
Gene Name Slc12a5
Accession Number NM_134363.1
Gene ID 171373
Species Rat
Product Type Adeno-associate virus(AAV) plasmid (overexpression)
Insert Length 3351 bp
Gene Alias Kcc2
Fluorescent Reporter Null
Mammalian Cell Selection Null
Fusion Tag HA (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGCTCAACAACCTGACGGACTGCGAGGACGGCGATGGGGGAGCCAACCCGGGTGACGGCAATCCCAAGGAGAGCAGCCCCTTCATCAACAGCACGGACACGGAGAAGGGGAGAGAGTATGATGGCAGGAACATGGCCCTGTTTGAGGAGGAGATGGACACCAGCCCCATGGTATCCTCCCTGCTCAGTGGGCTGGCCAACTACACCAACCTGCCTCAGGGAAGCAAAGAGCACGAAGAAGCAGAAAACAATGAGGGCGGAAAGAAGAAGCCGGTGCAGGCCCCACGCATGGGCACCTTCATGGGCGTGTACCTCCCGTGCCTGCAGAACATCTTTGGTGTTATCCTCTTTCTGCGGCTCACTTGGGTGGTGGGAATCGCAGGCATCATGGAGTCCTTCTGCATGGTCTTCATCTGCTGCTCCTGCACGATGCTCACAGCCATTTCCATGAGCGCAATTGCAACCAATGGTGTTGTGCCTGCTGGTGGCTCCTACTACATGATTTCCAGGTCTCTGGGCCCGGAGTTTGGGGGCGCCGTGGGCCTCTGCTTCTACCTGGGCACTACCTTTGCTGGGGCTATGTACATCCTGGGCACCATCGAGATCCTGCTGGCTTACCTCTTCCCAGCGATGGCCATCTTCAAGGCAGAAGATGCCAGTGGGGAGGCAGCCGCCATGTTGAATAACATGCGGGTGTATGGCACCTGTGTGCTCACCTGCATGGCCACCGTAGTCTTTGTGGGCGTCAAGTACGTGAACAAGTTTGCCCTGGTCTTCCTGGGTTGCGTGATCCTCTCCATCCTGGCCATCTACGCAGGGGTCATCAAGTCTGCCTTCGATCCACCCAATTTCCCGATTTGCCTCCTGGGGAACCGCACGCTGTCTCGCCATGGCTTTGATGTCTGTGCCAAGCTGGCTTGGGAAGGAAATGAGACAGTGACCACACGGCTCTGGGGCCTATTCTGTTCCTCCCGCCTCCTCAATGCCACCTGTGATGAGTACTTCACCCGAAACAATGTCACAGAGATCCAGGGCATTCCTGGTGCTGCAAGTGGCCTCATCAAAGAGAACCTGTGGAGTTCCTACCTGACCAAGGGGGTGATCGTGGAGAGGCGTGGGATGCCCTCTGTGGGCCTGGCAGATGGTACCCCCGTTGACATGGACCACCCCTATGTCTTCAGTGATATGACCTCCTACTTCACCCTGCTTGTTGGCATCTATTTCCCCTCAGTCACAGGGATCATGGCTGGCTCGAACCGGTCCGGAGACCTGCGGGATGCCCAGAAGTCTATCCCTACTGGAACTATCTTGGCCATTGCTACGACCTCTGCTGTCTACATCAGCTCTGTTGTTCTGTTCGGAGCCTGCATCGAAGGGGTCGTCCTACGGGACAAGTTTGGGGAAGCTGTGAATGGCAATCTGGTGGTGGGCACCCTGGCCTGGCCTTCTCCTTGGGTCATTGTCATAGGCTCTTTCTTCTCTACCTGCGGAGCTGGACTACAGAGCCTCACAGGGGCCCCACGCCTGCTGCAGGCCATCTCCCGGGATGGCATAGTGCCCTTCCTGCAGGTCTTTGGCCATGGCAAAGCCAACGGAGAGCCAACCTGGGCGCTGCTGCTGACTGCCTGCATCTGTGAGATCGGCATCCTCATCGCCTCCCTGGATGAGGTCGCCCCTATCCTTTCCATGTTCTTCCTGATGTGTTACATGTTTGTGAACTTGGCTTGCGCGGTGCAGACACTGCTGAGGACGCCCAACTGGAGGCCACGCTTCCGATATTACCACTGGACCCTCTCCTTCCTGGGCATGAGCCTCTGCCTGGCCCTGATGTTCATTTGCTCCTGGTATTATGCGCTGGTAGCTATGCTCATCGCTGGCCTCATCTATAAGTACATCGAGTACCGGGGGGCAGAGAAGGAGTGGGGGGATGGGATCCGAGGCCTGTCTCTCAGTGCAGCTCGCTATGCTCTCTTGCGTCTGGAGGAAGGACCCCCGCATACAAAGAACTGGAGGCCCCAGCTACTGGTGCTGGTGCGTGTGGACCAGGACCAGAACGTGGTGCACCCGCAGCTGCTGTCCTTGACCTCCCAGCTCAAGGCAGGGAAGGGCCTGACCATTGTGGGCTCTGTCCTTGAGGGCACCTTTCTGGACAACCACCCTCAGGCTCAGCGGGCAGAGGAGTCTATCCGGCGCCTGATGGAGGCTGAGAAGGTGAAGGGCTTCTGCCAGGTAGTGATCTCCTCCAACCTGCGTGACGGTGTGTCCCACCTGATCCAATCCGGGGGCCTCGGGGGCCTGCAACACAACACTGTGCTAGTGGGCTGGCCTCGCAACTGGCGACAGAAGGAGGATCATCAGACATGGAGGAACTTCATCGAACTCGTCCGGGAAACTACAGCTGGCCACCTCGCCCTGCTGGTCACCAAGAATGTTTCCATGTTCCCCGGGAACCCTGAGCGTTTCTCTGAGGGCAGCATTGACGTGTGGTGGATCGTGCACGACGGGGGCATGCTCATGCTGTTGCCCTTCCTCCTGCGTCACCACAAGGTCTGGAGGAAATGCAAAATGCGGATCTTCACCGTGGCGCAGATGGATGACAACAGCATTCAGATGAAGAAAGACCTGACCACGTTTCTGTACCACTTACGAATTACTGCAGAGGTGGAAGTCGTGGAGATGCACGAGAGCGACATCTCAGCATACACCTACGAGAAGACATTGGTAATGGAACAACGTTCTCAGATCCTCAAACAGATGCACCTCACCAAGAACGAGCGGGAACGGGAGATCCAGAGCATCACAGATGAATCTCGGGGCTCCATTCGGAGGAAGAATCCAGCCAACACTCGGCTCCGCCTCAATGTTCCCGAAGAGACAGCTTGTGACAACGAGGAGAAGCCAGAAGAGGAGGTGCAGCTGATCCATGACCAGAGTGCTCCCAGCTGCCCTAGCAGCTCGCCGTCTCCAGGGGAGGAGCCTGAGGGGGAGGGGGAGACAGACCCAGAGAAGGTGCATCTCACCTGGACCAAGGATAAGTCAGCGGCTCAGAAGAACAAAGGCCCCAGTCCCGTCTCCTCGGAGGGGATCAAGGACTTCTTCAGCATGAAGCCGGAGTGGGAAAACTTGAACCAGTCCAACGTGCGGCGCATGCACACAGCTGTGCGGCTGAACGAGGTCATCGTGAATAAATCCCGGGATGCCAAGTTGGTGTTGCTCAACATGCCCGGGCCTCCCCGCAACCGCAATGGAGATGAAAACTACATGGAATTCCTGGAGGTCCTCACTGAGCAACTGGACCGGGTGATGCTGGTCCGCGGTGGTGGCCGAGAGGTCATCACCATCTACTCCTGA
ORF Protein Sequence MLNNLTDCEDGDGGANPGDGNPKESSPFINSTDTEKGREYDGRNMALFEEEMDTSPMVSSLLSGLANYTNLPQGSKEHEEAENNEGGKKKPVQAPRMGTFMGVYLPCLQNIFGVILFLRLTWVVGIAGIMESFCMVFICCSCTMLTAISMSAIATNGVVPAGGSYYMISRSLGPEFGGAVGLCFYLGTTFAGAMYILGTIEILLAYLFPAMAIFKAEDASGEAAAMLNNMRVYGTCVLTCMATVVFVGVKYVNKFALVFLGCVILSILAIYAGVIKSAFDPPNFPICLLGNRTLSRHGFDVCAKLAWEGNETVTTRLWGLFCSSRLLNATCDEYFTRNNVTEIQGIPGAASGLIKENLWSSYLTKGVIVERRGMPSVGLADGTPVDMDHPYVFSDMTSYFTLLVGIYFPSVTGIMAGSNRSGDLRDAQKSIPTGTILAIATTSAVYISSVVLFGACIEGVVLRDKFGEAVNGNLVVGTLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAISRDGIVPFLQVFGHGKANGEPTWALLLTACICEIGILIASLDEVAPILSMFFLMCYMFVNLACAVQTLLRTPNWRPRFRYYHWTLSFLGMSLCLALMFICSWYYALVAMLIAGLIYKYIEYRGAEKEWGDGIRGLSLSAARYALLRLEEGPPHTKNWRPQLLVLVRVDQDQNVVHPQLLSLTSQLKAGKGLTIVGSVLEGTFLDNHPQAQRAEESIRRLMEAEKVKGFCQVVISSNLRDGVSHLIQSGGLGGLQHNTVLVGWPRNWRQKEDHQTWRNFIELVRETTAGHLALLVTKNVSMFPGNPERFSEGSIDVWWIVHDGGMLMLLPFLLRHHKVWRKCKMRIFTVAQMDDNSIQMKKDLTTFLYHLRITAEVEVVEMHESDISAYTYEKTLVMEQRSQILKQMHLTKNEREREIQSITDESRGSIRRKNPANTRLRLNVPEETACDNEEKPEEEVQLIHDQSAPSCPSSSPSPGEEPEGEGETDPEKVHLTWTKDKSAAQKNKGPSPVSSEGIKDFFSMKPEWENLNQSNVRRMHTAVRLNEVIVNKSRDAKLVLLNMPGPPRNRNGDENYMEFLEVLTEQLDRVMLVRGGGREVITIYS

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector vGMAAV000414 Rat Slc12a5 Adeno-associate virus(AAV) particle




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.